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Abstract
ELISA-based methods of detecting Fasciola cathepsins in feces are powerful techniques
for diagnosing infections by F. hepatica and F. gigantica. In the last decade, the in-house
MM3-COPRO ELISA and its commercial version BIO K 201 (BIO X Diagnostics, Belgium)
have been recognized as useful tools for detecting early infections by such trematodes and
for monitoring the efficacy of anthelmintic treatments in human and animal species, as they
provide some advantages over classic fecal egg counts. However, the sensitivity of MM3-
COPRO ELISA can sometimes be compromised by the high variability in the concentration
of cathepsins in fecal samples throughout the biological cycle of Fasciola (mainly in cattle)
and by differences in the between-batch performance of peroxidase-labeled anti-mouse
IgG polyclonal antibodies. To prevent such problems, we investigated whether the incorpo-
ration of a commercial streptavidin-polymerized horseradish peroxidase conjugate, in order
to reveal bound biotinylated monoclonal antibody MM3, can improve the sensitivity of the
MM3-COPRO ELISA. We observed that inclusion of this reagent shifted the previous detec-
tion limit of the assay from 0.6 ng/mL to 150 pg/mL and that the modified test is able to iden-
tify infection in cows harboring only one fluke. Moreover, we demonstrated that maximal OD
values can be achieved with short incubations (30 min each step) at RT with shaking, rather
than standard incubations, which significantly accelerates the diagnostic procedure. Finally,
we did not find a significant correlation between coproantigen concentration and parasite
burden in cattle, which may be due to the low parasite burden (1–10 adult flukes) of the ani-
mals used in the present study. As the usefulness of the classic MM3-COPRO test for
detecting animal and human infections has already been demonstrated, it is expected that
the improvements reported in this study will add new insights into the diagnosis and control
of fasciolosis.
Author Summary
We have previously reported how the combined use of mAb MM3 with polyclonal anti-
bodies obtained from rabbit immunized with Fasciola hepatica excretory-secretory
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antigens led to the development of the in-house MM3-COPRO ELISA and its commercial
version BIO K 201 (BIO X Diagnostics, Belgium), which are widely used to detect human
and animal infections caused by F. hepatica. After more than a decade in use, both tests
have proven to be useful tools for specifically detecting Fasciola infections, although it has
also been found that: i) the conditions of use of the commercial test in some field studies
did not enable the sensitivity obtained with the in-house test to be reached, and ii) the
batches of the secondary reagent (peroxidase-labeled anti-mouse antibodies) currently
available for use in the in-house test do not perform the same as previous batches. To
solve these problems, we provide data showing that the incorporation of an enhancement
system consisting of streptavidin-polymerized horseradish peroxidase conjugate greatly
improved the sensitivity of the MM3-COPRO ELISA and enabled reduction of the incuba-
tion time. These modifications enabled the detectability of the assay to be 150 pg/mL, thus
enabling detection of infection in animals harboring only one fluke.
Introduction
Fascioliasis (= fasciolosis) is a worldwide emergent zoonotic disease produced by infection
with trematodes of the genus Fasciola. The two main species of this genus, F. hepatica and F.
gigantica, are pathogenic to humans and livestock [1]. Considering the worldwide distribution,
F. gigantica is the only species present in Western Africa, while F. hepatica is the only species
present in Europe, the Americas, Australia and the African Magreb [2]. However, both species
have been reported to coexist in Eastern and Southern Africa as well as in several regions of
Asia [3]. The existence of two species with overlapping regions has implications for developing
sensitive diagnostic tests of general application.
Typically, diagnosis of human and animal infections caused by Fasciola species is carried
out by coproscopy or immunological techniques, including determination of circulating anti-
gens in serum, measurement of coproantigens and detection of serum antibodies [4, 5].
Although coprological techniques are advantageous in terms of the cheapness of laboratory
material and detection of active infections, they are time-consuming, require expert personnel
and have poor sensitivity. Serological methods have the advantage of permitting easy automa-
tion, which is of great interest for handling large volume of samples. These methods are also
very sensitive and can be used for early monitoring of Fasciola infections in herds by using
either serum or milk samples [6]. However, these techniques do not differentiate between anti-
bodies induced by current infections/reinfections and those still present in animals or humans
successfully treated with anthelmintics during the course of a past Fasciola infection. Methods
for detecting circulating Fasciola antigens and/or coproantigens solve the above mentioned
problems associated with coprological and serological techniques. However, detection of
coproantigens is preferred as sampling is not invasive and the presence of antigens in feces is
not limited by time, as may occur with circulating antigens. Moreover, these methods are of
widespread application, as the same techniques can be used to detect Fasciola coproantigens in
fecal samples from humans and animal species.
In the past decades, several capture ELISA methods that use monoclonal and/or polyclonal
antibodies were reported to be able to detect small amounts of specific Fasciola coproantigens
in fecal samples [7–10]. However, since then, only the BIO K 201 kit (BIO X Diagnostics, Bel-
gium), i.e. the commercial version of MM3-COPRO ELISA [9], has been globally used. Since
being commercialized (in 2007), both versions of the test have been recognized as valuable
diagnostic tools for detecting Fasciola infections or for monitoring the efficacy of treatment
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with anthelmintics in several studies [9–16]. Nevertheless, during years of use of the MM3-E-
LISA tests, two drawbacks have also been highlighted: i) the difficulty with the commercial test
[17–20], which uses avidin-horseradish peroxidase (HRP) as a secondary conjugate, in main-
taining the sensitivity of the original in-house MM3-COPRO test, and ii) the dependence of
the in-house MM3-COPRO test on particular batches of HRP-labeled anti-mouse IgG antibod-
ies, for yielding good sensitivity and specificity. To prevent these disadvantages and to guaran-
tee a homogeneous and highly sensitive product, we investigated the possibility of substituting
the above secondary reagents with a streptavidin (SA)-polymerized HRP (PolyHRP) detection
system and evaluated the conditions of use of this reagent. We found that this ELISA enhance-
ment system is an improvement on classic secondary reagents as it increases the sensitivity of
the above ELISA tests while enabling a reduction in the incubation time required.
Materials and Methods
Ethics statement
The biological samples used in the present study were of animal origin (sheep and cattle) and
were obtained from a collection of frozen fecal samples stored at INGACAL (Mabegondo, A
Coruña, Spain). The samples were obtained during routine diagnostic procedures and from
experimental infections with F. hepatica reported in previous studies [9, 21, 22].
Fasciola hepatica excretory-secretory antigens
Fasciola excretory-secretory antigens (ESAs) were obtained as previously described [23, 24].
Briefly, live adult flukes collected from bile ducts of naturally infected cows were washed, first
in sterile saline and glucose (2 g/L) at 38°C and then in RPMI 1640 cell culture medium supple-
mented with 20 mMHEPES, 0.3 g/L L-glutamine, 2 g/L sodium bicarbonate and antibiotics
(penicillin and streptomycin) at 38°C under 5% CO2 in air. The flukes were then transferred to
75-cm2 tissue culture flasks and maintained in culture medium (3 mL/fluke) at 38°C under 5%
CO2 in air. After incubation for 24 h, the medium containing ESAs was removed and centri-
fuged at 10,000 g for 20 min at 4°C in the presence of protease inhibitors (SigmaFast Protease
Inhibitor Tablets; Sigma-Aldrich, Madrid, Spain). The supernatant was passed through a
0.45 μm pore filter disk and concentrated in an Amicon 8050 ultrafiltration cell (Amicon, Inc.,
Beverly, MA) equipped with a YM10 membrane (10 kDa cut-off), dialyzed against PBS, steril-
ized by filtration, and stored at -80°C until required. Protein concentration was measured
using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Barcelona, Spain).
Fecal samples
Cattle. Positive and negative fecal samples were collected in the slaughterhouse from
respectively adult cattle (Friesian and ‘Rubia Gallega’ breed) naturally infected with F. hepatica
and cattle free of F. hepatica (S1 Fig). After the animals were slaughtered, the livers were exam-
ined, and all flukes were collected and counted (gold standard of infection). The absence of F.
hepatica infection in negative cattle was also confirmed serologically by the MM3-SERO test
[21]. All fecal samples were analyzed microscopically to detect the presence of eggs by a quanti-
tative sedimentation technique [25], and tested for the presence of Fasciola coproantigens
using the classic MM3-COPRO ELISA test (hereafter referred to as model A) [9] before the
samples were stored frozen until analysis by other variants of the test evaluated (models B, C
and D). For comparison between the different MM3-COPRO ELISA models evaluated in the
present study, only samples from animals with low parasite burden (1–10 flukes; n = 18) were
investigated. Also, among the negative cattle (n = 30), some were naturally infected with
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Calicophoron daubneyi (counts ranging from 103 to 11,895 flukes; n = 9) and intestinal nema-
todes were also present in most animals.
For experimental infections, four cows reared under Fasciola-free conditions were infected
once with 25 (n = 2) and 50 (n = 2) F. hepaticametacercariae obtained in our laboratory from
experimentally infected Galba truncatula snails. Fecal samples were obtained before the infec-
tion and weekly for 48 weeks postinfection (wpi). At the end of the experiment (48 wpi), one
cow was slaughtered and liver parasites collected.
Sheep. All sampled sheep were of the Galician autochthonous breed. Negative fecal sam-
ples were collected from sheep reared on a Fasciola-free farm (n = 18; most of which had intes-
tinal and lung nematodes) and from negative sheep experimentally infected with Dicrocoelium
dentriticum (n = 2). Positive samples (n = 16) were obtained from 4-month-old lambs reared
under Fasciola-free conditions and subsequently infected once with 5 (n = 6), 10 (n = 5), 20
(n = 2), or 40 (n = 3) F. hepaticametacercariae (S1 Fig). Fecal samples were collected immedi-
ately before infection and weekly thereafter. All samples were stored frozen at -20°C until use.
At 13 wpi, ten randomly chosen animals were sacrificed and necropsied to confirm infection.
Among these animals, one was parasitized with 28 flukes and the remaining sheep had 13 or
fewer flukes. The remaining sheep were maintained to examine the kinetics of coproantigen
release until 18 wpi. Infection of these animals was also confirmed by necropsy.
Processing fecal samples for ELISA determinations
Fresh or stored (-20°C) individual ovine and bovine stools were mixed with distilled water at a
ratio of 1:4 (1 g + 4 mL) or 1:1 (3 g + 3 mL), respectively. The samples were resuspended by
mixing on a vortex mixer and centrifuged for 15 min at 1,000 g. The supernatants were col-
lected and subsequently analyzed for the presence of F. hepatica coproantigens by ELISA.
To evaluate the detectability of the MM3-COPRO test with three secondary reagents, a pool
of 6 negative cattle fecal samples were mixed with distilled water, and the supernatant was col-
lected as described previously. The supernatants were used to prepare two-fold dilutions of F.
hepatica ESAs starting at 20 ng/mL prior to ELISA analysis.
Adjustment of MM3-COPRO ELISA conditions
Determination of optimal conditions for use of SA-PolyHRP. ELISA plates were pre-
pared as previously described [10] and used to perform all experiments in the present study.
Polystyrene microtiter 1x8 F strip plates (Greiner Bio-One; Soria-Melguizo, Madrid, Spain)
were coated overnight (ON) with 100 μL/well of rabbit anti-Fasciola polyclonal IgG antibodies
(wells in the odd-numbered rows) or polyclonal IgG antibodies from non-immunized rabbits
(wells in the even-numbered rows) at 10 μg/mL in PBS. Plates were washed three times with
PBS and blocked with 1.5% of sodium caseinate in PBS for 1 h at room temperature (RT).
Two concentrations of F. hepatica ESAs (5 and 0.62 ng/mL) diluted in CoproGuard [10]
were added in quadruplicate (two odd-numbered wells plus two even-numbered wells) and the
plates were incubated for 30 min at RT with shaking at 750 rpm on a microtiter plate shaker
(orbit diameter: 1.5 mm). The plates were washed 6 times with PBS containing 0.05% Tween
20 (PBS-T) before 100 μL/well of biotinylated monoclonal antibody (mAb) MM3 diluted 1/
10,000 in PBS-T containing 1% BSA (fraction V, Sigma-Aldrich; PBS-T-BSA) was added and
the plates were incubated for 30 min at RT with shaking at 750 rpm. The plates were washed
again and incubated with the SA-PolyHRP conjugate (Pierce, Thermo Fisher Scientific) at dif-
ferent concentrations (1/5,000, 1/6,500, 1/8,000, 1/10,000) in PBS-T-BSA for 30 min at RT
with shaking at 750 rpm. After a washing step, the substrate OPD (SigmaFast OPD, Sigma-
Aldrich) was added (100 μL/well) and incubated for 20 min at RT, and the reaction was
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stopped by addition of 3 N H2SO4 (25 μL/well). Finally, the optical density (OD) was measured
at 492 nm. The OD value for each sample was calculated as OD1–OD2, where OD1 is the
mean for the 2 odd-numbered wells (coated with anti-Fasciola polyclonal antibodies), and
OD2 is the mean for the 2 even-numbered wells (coated with irrelevant polyclonal antibodies).
Once the optimal dilution of SA-PolyHRP was selected (1/8,000), an ELISA was conducted
under the same conditions with the exception of the antigen incubation step. In this assay,
two-fold dilutions of ESAs ranging from 5 ng/mL to 0.15 ng/mL in CoproGuard were incu-
bated for 30 min, 1 h and 2 h at RT with agitation.
For the initial assays, the preservative CoproGuard was used to dilute ESAs because the anti-
gens cannot be optimally detected by MM3-COPRO ELISA if diluted in distilled water. This
may be due to lowered affinity between coated antibodies and the recognized antigens under
conditions of low ionic strength. However, for subsequent studies using fecal samples, we used
distilled water for the extraction because it is widely used and its use enabled comparison with
data obtained with the classic MM3-COPRO ELISA (model A), which was performed follow-
ing the method described by Mezo et al. [9].
Performance of three HRP-labeled secondary detection reagents under different incuba-
tion conditions. The ELISA test was performed by adding in quadruplicate (2 odd-numbered
wells plus 2 even-numbered wells) two-fold dilutions of ESAs starting at 20 ng/mL in Copro-
Guard and incubating the plates under different conditions: ON at 4°C or 2 h at 37°C (standard
incubations), and for 30 min at RT with shaking at 750 rpm (short incubations). Monoclonal
antibody MM3 and three different secondary reagents were subsequently added after a washing
step with PBS-T. Both incubation steps were performed for 90 min and 1 h, respectively, at
37°C (standard incubations), or for 30 min at RT with shaking at 750 rpm each (short incuba-
tions). Biotinylated MM3 (1/10,000) and PBS-T-BSA (as dilution buffer) were used for the
NeutrAvidin (NA)-HRP (Pierce, Thermo Fisher Scientific; dilution 1/2,000) and SA-PolyHRP
conjugates (dilution 1/8,000). Unlabeled MM3 diluted 1/2,000 and PBS-T containing 1%
skimmed dry milk (PBS-T-SM) were used for the HRP-labeled goat anti-mouse IgG secondary
antibodies (EIA grade, Bio-Rad, Madrid, Spain; dilution 1/3,000). This conjugate is referred to
as the “current batch” throughout the manuscript for comparative studies with a “former
batch” of the same commercial source. The plates were then washed, the OPD substrate was
added and the OD values were read as described above.
Once the optimal incubation conditions were determined (incubation of 30 min with shak-
ing at 750 rpm for all incubation steps), an ELISA was performed to evaluate the performance
of the three detection reagents in the presence of fecal samples. The same dilutions of ESAs
were prepared in fecal supernatants obtained from a pool of 6 negative cattle fecal samples and
were tested under the selected conditions. In addition, the SA-PolyHRP conjugate was tested
with two HRP chromogens: OPD and TMB (TMB microwell peroxidase substrate system;
KPL, Inc., MD, USA). After TMB substrate was added (100 μL/well) and incubated for 5 min
at RT, the reaction was stopped by addition of an equal volume of 1 M H3PO4 and the OD val-
ues were measured at 450 nm. The OD value for each sample was calculated as mentioned
above (by subtracting the mean OD value of wells with irrelevant antibodies from the mean
OD value of wells with anti-Fasciola antibodies).
Detection of F. hepatica coproantigens in ovine and bovine feces
ELISA model A. This method corresponds to the classic MM3-COPRO ELISA [9], which
was performed at the time of sample collection. Each fecal supernatant was added in quadrupli-
cate (2 odd-numbered wells plus 2 even-numbered wells) and incubated ON at 4°C. The plates
were washed 6 times with PBS-T, and mAb MM3 diluted 1/2,000 in PBS-T-SM was added to
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each well and incubated for 90 min at 37°C. Bound MM3 was detected by incubation, first with
a former batch of HRP-labeled goat anti-mouse IgG antibodies (EIA grade, Bio-Rad) diluted 1/
3,000 in PBS-T-SM for 1 h at 37°C and then with OPD, after a washing step. The OD value for
each sample was calculated as OD1-OD2, where OD1 is the mean value for wells coated with
anti-Fasciola antibodies and OD2 is the mean value for wells coated with irrelevant antibodies.
The same formula was applied for models B, C and D.
ELISA models B and C. Each fecal supernatant was added in quadruplicate, as above, and
incubated for 30 min at RT with shaking at 750 rpm (short incubations). Biotinylated MM3
diluted 1/10,000 and SA-PolyHRP diluted 1/8,000 in PBS-T-BSA were subsequently added and
incubated for short incubations, after the corresponding washing steps. Finally, OPD (model
B) or TMB (model C) substrates were added and after incubation for respectively 20 and 5
min, the reactions were stopped as indicated above and the plates were read at respectively 492
nm and 450 nm.
ELISA model D. This method was performed with the same reagents as model A but
short incubations of 30 min at RT with shaking at 750 rpm were applied. However, the HRP-
labeled goat anti-mouse IgG antibodies used corresponded to a new batch of antibodies from
the same commercial source (current batch), which exhibited poorer performance than the for-
mer batch used in model A.
Statistical analysis
The limit of detection for each MM3-COPRO ELISA performed with different secondary
reagents and incubation conditions was calculated by testing serial dilutions of known amounts
of F. hepatica ESAs in CoproGuard or in fecal supernatants from pooled negative samples pre-
pared in distilled water. The concentration obtained at the intersection point of the standard
curve with the respective cut-off value of each MM3-COPRO ELISA was considered the limit
of detection of the assay. The concentrations of the ESAs assayed ranged from 0.15 to 20 ng/
mL.
The cut-offs for cattle and sheep were determined for each ELISA model on the basis of val-
ues obtained for fecal supernatants from animals not infected with F. hepatica. Specifically, the
cut-offs were determined as being 1 standard deviation (SD) above the highest OD value
observed on testing the negative samples from fluke-free cattle and sheep populations. Values
higher than this cut-off were considered positive for F. hepatica infection. This particular
method of calculating the cut-off [26] was preferred over other commonly used arbitrary meth-
ods based on a statistical parameter such as 2–4 SD above the mean value of negative samples
[9, 27]. This ensured maximal specificity while preventing the penalizing effect of the SD
parameter when combining a high number of OD values that are close to zero with few data
with higher values among negative samples.
The calculated cut-off values were 0.059 (cattle) for ELISA model A (HRP-labeled goat anti-
mouse IgG antibodies, former batch), 0.055 (cattle) and 0.064 (sheep) for ELISA model B
(SA-PolyHRP and OPD), 0.084 (cattle) and 0.065 (sheep) for ELISA model C (SA-PolyHRP
and TMB) and 0.224 (cattle) for ELISA model D (HRP-labeled goat anti-mouse IgG antibodies,
current batch). As the secondary NA-HRP reagent was only used for comparison in prelimi-
nary ELISA experiments, a specific cut-off was not calculated. Instead, the same cut-off value
of SA-PolyHRP was considered as a reference.
Linear correlation coefficients were used to test the relationship between parasite burden
and OD values measured by the MM3-COPRO test and between different MM3-COPRO
models. The analysis was implemented using the GradPad Instat statistical package (GraphPad
Software Inc, CA, USA).
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Results
Optimizing ELISA conditions for the use of SA-PolyHRP as a secondary
reagent for the MM3-COPRO test
In order to evaluate the usefulness of SA-PolyHRP as a secondary reagent for quantitation of
Fasciola cathepsins in fecal samples, we first determined the optimal dilution of this reagent
and incubation time for samples. The optimization procedure was carried out at RT under
shaking and considering several concentrations of antigen diluted in CoproGuard. The data
presented in Fig 1A show that the commercial SA-PolyHRP conjugate can be optimally used in
the range of 1/5,000-1/10,000 dilution for either medium (5 ng/mL) or low-range (0.62 ng/mL)
concentrations of antigen. The data in Fig 1B also indicate that a reduction in the incubation
time from 2 h to 30 min under orbital shaking does not decrease the sensitivity of the assay for
the overall range of antigen concentrations tested (5 to 0.15 ng/mL), even when incubations
were carried out at RT. According to the data obtained, we selected a 1/8,000 dilution and incu-
bations of 30 min at RT with shaking for subsequent comparative experiments.
The sensitivity of the MM3-COPRO ELISA can be improved using
SA-PolyHRP
To investigate whether the sensitivity of previous versions of the MM3-COPRO ELISA test can be
improved using the SA-PolyHRP system, we compared the OD values obtained with three second-
ary detection reagents (NA-HRP, HRP-labeled anti-mouse IgG antibodies and SA-PolyHRP), and
three incubation conditions: i) 37°C (2 h for samples; 90 min and 1 h for secondary reagents) for
all incubation steps, ii) 4°C (ON) for incubation of samples, and 37°C (90 min and 1 h) for subse-
quent steps, and iii) RT (30 min) with shaking at 750 rpm for all incubation steps. For these experi-
ments, we tested several concentrations of Fasciola ESAs diluted in CoproGuard. Comparing the
three detection methods, the data in Fig 2A–2D show that SA-PolyHRP provides an advantage
over classic HRP-labeled anti-mouse IgG antibodies and NA-HRP detection systems and that
incubation for a short period at RT under shaking yields better OD values than longer incubations
at 37°C or at 4°C. In particular, for short incubations with agitation (Fig 2D), we observed that the
use of SA-PolyHRP in the MM3-COPRO test provided a limit of detection (150 pg/mL) that is
about 8 and 16 times lower than that obtained using NA-HRP (1.25 ng/mL) and HRP labeled
anti-mouse IgG antibodies (2.5 ng/mL), respectively. When pooled supernatants from negative
fecal samples (cattle) extracted with distilled water were used to dilute Fasciola ESAs, the OD val-
ues for the different antigen concentrations were slightly lower (Fig 3A) than those obtained for
the antigen diluted in CoproGuard (Fig 2D); however, the detection limits remained the same for
the three secondary reagents tested. Moreover, we observed that the current batch of HRP-labeled
anti-mouse antibodies used to perform these experiments yielded a higher background with nega-
tive samples in wells containing anti-Fasciola antibodies than in control wells with irrelevant anti-
bodies, which was not previously observed with former batches. This effect, which occurred with
CoproGuard and with fecal supernatants diluted in distilled water, explains why the OD values of
the standard curve obtained with this secondary reagent did not fall below ∽0.200 at concentra-
tions lower than the limit of detection (2.5 ng/ml) (Figs 2C, 2D and 3A).
In addition to the use of enhanced detection systems, ELISA OD values can also be
increased by using certain substrates for peroxidase, among which OPD and TMB are fre-
quently used. Comparative results for these two peroxidase substrates are presented in Fig 3B,
which shows that the OD values were higher, as expected, with TMB; however, the detectability
of the assay (i.e., the smallest amount of analyte detected) [28] did not change as signals in con-
trol wells were also higher with TMB.
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Enhancement of MM3-COPRO ELISA signals with SA-PolyHRP did not
alter the specificity but increased the sensitivity of the test
In order to determine the sensitivity and specificity of the MM3-COPRO test by using the
SA-PolyHRP secondary reagent and to obtain a cut-off value, we evaluated its ability to
Fig 1. Adaptation of the SA-PolyHRP conjugate and rapid incubations to the MM3-COPRO ELISA. (A)
Two concentrations (5 and 0.62 ng/mL) of whole Fasciola hepatica excretory-secretory antigens (Ag) diluted
in CoproGuard were tested with the MM3-COPRO ELISA by using several dilutions of SA-PolyHRP (ranging
from 1/10,000 to 1/5,000) as secondary reagent to reveal bound biotinylated mAbMM3. All incubation steps
were performed at RT for 30 min with shaking (750 rpm). (B) Two-fold dilutions (0.15–5 ng/mL) of Ag diluted
in CoproGuard were assayed with the MM3-COPRO ELISA (SA-PolyHRP diluted 1/8,000) at RT with
shaking for several incubation times (30 min, 1 h and 2 h).
doi:10.1371/journal.pntd.0004872.g001
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correctly classify positive and negative bovine and ovine fecal samples. Two peroxidase sub-
strates, OPD and TMB, were also evaluated. The data in Fig 4 show the results obtained with
positive and negative samples with the classic MM3-COPRO ELISA (model A, using a former
batch of HRP-labeled goat anti-mouse IgG polyclonal antibodies and performed at the time of
sample collection), the enhanced MM3-COPRO revealed with SA-PolyHRP and OPD (model
B) or TMB (model C), and the MM3-COPRO performed using a current batch of goat anti-
mouse IgG-HRP conjugate (model D). As indicated in the previous section, negative samples
(open circles) from cattle (Fig 4A) and sheep (Fig 4B) were used to calculate the cut-off value
for each model. Regarding the positive bovine samples (Fig 4A, closed circles), models B and C
Fig 2. Comparison of three HRP-labeled secondary reagents and several incubation conditions in MM3-COPRO ELISA. The detectability of the
MM3-COPRO ELISA was determined by testing two-fold dilutions (0.15–20 ng/mL) of Fasciola excretory-secretory antigens (Ag) diluted in CoproGuard, and
bound mAbMM3 was revealed with (A) NA-HRP, (B) HRP-labeled anti-mouse IgG antibodies (anti-mouse-HRP) or (C) SA-PolyHRP. The following
incubation conditions were considered: 37°C (2 h for samples; 90 min and 1 h for secondary reagents; open circles); 4°C (ON) for incubation of samples and
37°C (90 min and 1 h) for subsequent steps (open triangles); and RT (30 min) with shaking at 750 rpm for all incubation steps (closed squares). (D)
Combined data obtained with the three secondary reagents and short incubations at RT (30 min, 750 rpm). The colored lines show the cut-off values
calculated for anti-mouse-HRP (OD = 0.224; blue line) and SA-PolyHRP (OD = 0.055; red line) by using negative samples from cattle.
doi:10.1371/journal.pntd.0004872.g002
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were able to correctly classify all samples and the signal-to-noise ratios were optimal for both.
Nevertheless, as expected, higher OD values and cut-off values were obtained when SA-Po-
lyHRP secondary reagent and the TMB substrate were combined (model C, cut-off
Fig 3. Detectability of rapid MM3-COPRO ELISA performed with three HRP-labeled secondary
reagents and two HRP substrates. Two-fold dilutions (0.15–20 ng/mL) of Fasciola hepatica excretory-
secretory antigens (Ag) diluted in fecal supernatants obtained from pooled negative samples from cattle
(prepared with distilled water) were tested under short incubations (30 min, 750 rpm) at RT with (A) HRP-
labeled anti-mouse IgG antibodies (triangles; cut-off OD = 0.224, blue line), SA-PolyHRP (squares; cut-off
OD = 0.055, red line) and NA-HRP (circles), revealed with OPD substrate; and (B) SA-PolyHRP revealed with
two HRP substrates, OPD (squares; cut-off OD = 0.055, dashed red line) and TMB (circles; cut-off
OD = 0.084, dashed blue line).
doi:10.1371/journal.pntd.0004872.g003
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value = 0.084) than with the OPD substrate (model B, cut-off value = 0.055). Unlike the
enhanced MM3-COPRO methods (models B and C), models A and D yielded poorer results
with multiple mismatches. In particular, the accuracy of these models was highly dependent on
the performance of each batch of polyclonal antibodies. Overall, the results obtained with
model A were acceptable, as of the three false negative samples, two corresponded to animals
harboring a single fluke and the other corresponded to an animal harboring 4 flukes but with
an OD signal (OD = 0.056) close to the cut-off value (OD = 0.059). However, with model D,
the results were diagnostically unacceptable, as the cut-off value was very high (OD = 0.224)
and consequently 10/18 positive samples (55.6%) were incorrectly classified. Positive fecal sam-
ples from experimentally infected sheep were also tested with enhanced models B and C (Fig
4B, closed circles). All samples produced a high response and no significant differences were
observed on comparing the OD values from animals harboring low fluke burdens (2–5 flukes,
6 animals) and those harboring medium to high fluke burdens (12–28 flukes, 4 animals).
Model A was also used to analyze sheep samples at the time of sample collection and also cor-
rectly classified the samples.
Correlation between MM3-COPROmodels and fluke burden, and
kinetics of coproantigen release
Considering samples from cattle naturally infected with F. hepatica (n = 18), a close correlation
(Fig 5A and 5B) was observed on comparing the classic MM3-COPRO ELISA (model A) with
Fig 4. MM3-COPROOD values obtained for individual Fasciola hepatica positive and negative cattle and sheep
feces. (A) F. hepatica positive (n = 18, closed circles) and negative (n = 30, open circles) samples from cows tested with
several variations of the MM3-COPRO test (models A-D). (B) F. hepatica positive (n = 10, closed circles) and negative
(n = 20, open circles) samples from sheep tested with models B and C. Model A: classic MM3-COPRO test, performed with
standard incubations and a former batch of HRP-labeled anti-mouse IgG antibodies. Model B: performed with short
incubations (30 min at RT with shaking), using SA-PolyHRP and OPD. Model C: same as model B, using TMB as substrate.
Model D: performed with short incubations and a current batch of HRP-labeled anti-mouse IgG antibodies. The red lines
correspond to the cut-off value of each ELISAmodel: 0.059 for model A (cattle); 0.055 (cattle) and 0.064 (sheep) for model
B; 0.084 (cattle) and 0.065 (sheep) for model C; and 0.224 (cattle) for model D.
doi:10.1371/journal.pntd.0004872.g004
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both enhanced MM3-COPRO ELISAs (model B and C; r = 0.846 and r = 0.850, respectively;
p<0.0001). As expected, the correlation coefficient was even higher when models B and C were
compared (Fig 5C; r = 0.951; p<0.0001). However, we did not observe a correlation between
fluke burden in liver and the OD values obtained with the MM3-COPRO ELISA, as shown for
the ELISA model B in Fig 5D (r = 0.2998; p = 0.2267). As additional data, the results in Fig 6
show the number of parasites collected from the liver, e.p.g. counts in feces, and the ELISA OD
values (model C) obtained for each animal. As expected, most samples (11/18) were negative
for the presence of eggs by microscopic examination. Among positive samples, the presence of
Fasciola eggs was low (ranging from 1 to 4 e.p.g., the latter corresponding to the only animal
harboring 10 flukes; sample #14).
Fig 5. Correlation between MM3-COPROmodels and fluke burden. Each point represents an individual cow naturally infected with Fasciola hepatica
(n = 18) and tested with several variations of the MM3-COPRO test. (A) Plot of the OD values measured by MM3-COPROmodel B (SA-PolyHRP and
OPD, rapid incubations) against model A (HRP-labeled anti-mouse IgG antibodies, former batch, and OPD, standard incubations). (B) Plot of the OD
values obtained with model C (SA-PolyHRP and TMB, rapid incubations) against model A. (C) Plot of the OD values measured by model C against model
B. (D) Plot of the OD values determined by model B against the number of flukes recovered at necropsy.
doi:10.1371/journal.pntd.0004872.g005
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Regarding the sensitivity of the enhanced MM3-COPRO ELISAs, it is also interesting to
determine whether the tests can correctly classify positive fecal samples collected at regular
intervals during the biliary phase of the parasite from animals infected with a small number
of metacercariae, considering the usual fluctuations in antigen concentration in feces. For
this purpose, we investigated the kinetics of coproantigen release in fecal samples obtained
sequentially (weekly) from lambs and cattle experimentally infected with different doses of F.
hepaticametacercariae during the patent period of infection. As the enhanced MM3-COPRO
ELISA performs similarly with OPD and TMB, only the former substrate was considered.
The data in Fig 7A show that the release of coproantigen in sheep remained high and stable
throughout the period of infection investigated (weeks 9–18). No differences were observed
for fecal samples obtained from animals infected with either 5 (fluke recovery of 53%; fluke
burdens: 2, 3 and 3) or 10 (fluke recovery of 30%; fluke burdens: 1, 3 and 5) metacercariae.
On the contrary, regarding fecal samples from positive cattle, very variable OD values were
obtained, although the test was able to correctly classify as positive all samples obtained from
each animal (Fig 7B). Again, no differences were observed on comparing samples from ani-
mals infected with either 50 or 25 metacercariae. Finally, in order to obtain information
about the number of flukes that reached adult stages in the infected cows, one animal infected
with 25 metacercariae was sacrificed in the slaughterhouse at the end of the experiment.
Only 3 adult flukes were found in liver. Although only one animal was slaughtered, this indi-
cates that the fluke burden in the animals used in this experiment was probably low as in the
group of 18 animals selected at slaughterhouse to test the sensitivity of the different ELISA
methods.
Fig 6. Fecal egg counts, fluke burden and OD values obtained by testing fecal samples from cows naturally infected with
Fasciola hepatica (n = 18) with the rapid enhanced MM3-COPRO ELISA. Fluke burdens were determined at necropsy. MM3-COPRO
ELISA was performed with short incubations (30 min at RT with shaking) and with SA-PolyHRP as secondary reagent, which was
revealed with TMB (model C).
doi:10.1371/journal.pntd.0004872.g006
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Discussion
Detection of minimum amounts of Fasciola L-cathepsins in fecal samples by capture ELISA
has emerged as one of the best ways of confirming early infections by this trematode in humans
Fig 7. OD values obtained with the rapid enhancedMM3-COPRO ELISA testing fecal samples from animals experimentally infected with
Fasciola hepatica. (A) Lambs were experimentally infected with 5 (n = 3) or 10 (n = 3) metacercariae. (B) Cows were infected with 25 (n = 2) and
50 (n = 2) metacercariae (Mc). Fecal samples were obtained weekly from each animal during the period of study and analyzed with the
MM3-COPRO test using SA-PolyHRP and OPD and short incubations (model B). The cut-off value is 0.064 for sheep and 0.055 for cattle.
doi:10.1371/journal.pntd.0004872.g007
Enhanced MM3-COPRO ELISA
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004872 July 20, 2016 14 / 20
and animal species and of monitoring the efficacy of anthelmintic treatments [5, 9]. Moreover,
as indicated by Valero et al. [29], some of these methods can be used for rapid mass screening,
early detection of treatment failure or re-infection in post-treated subjects and are also useful
for surveillance programs. In previous studies using our in-house MM3-COPRO ELISA [9],
we observed that only a low percentage of fecal samples from cows harboring one fluke (2/7 =
28.6%) tested positive, while all samples from animals parasitized with two or more flukes were
correctly classified. Using the same MM3-COPRO ELISA method (model A), we observed that
this ELISA was unable to correctly classify 2/4 (50%) of positive fecal samples from animals
harboring a single fluke and also that one sample from an animal harboring four flukes tested
negative. Moreover, the number of false negative results with samples from animals with a low
parasite burden increased substantially on using currently available HRP-conjugated anti-
mouse IgG polyclonal antibodies (model D), which prevented assessment of the overall perfor-
mance of the original MM3-COPRO ELISA (model A). Although the reasons why the results
obtained with polyclonal antibodies vary so greatly from batch to batch are not provided by the
manufacturing companies, we hypothesize that it may be due to variations in the immunologi-
cal response of the immunized animals and also to contaminants generated during immuniza-
tion and/or antibody purification procedures. For example, small amounts of A/G proteins, as
well as positively charged polymer fragments, released from either affinity or DEAE columns
during antibody purification, may generate high background levels [30]. In addition, purifica-
tion methods that do not isolate antigen-specific antibodies [31] can copurify anti-IgG anti-
bodies (if present) that might react with immunoglobulins from other species not used for
immunization. In particular, the latter situation may represent a strong source of background
in ELISAs that combine polyclonal and monoclonal antibodies, for capture and detection
steps, such as the MM3-COPRO and MM3-SERO ELISAs.
An alternative to peroxidase-labeled species-specific anti-IgG polyclonal antibodies is the
use of mAbs labeled with haptens such as FITC [32] or biotin [10, 33], which can be subse-
quently recognized by peroxidase-labeled anti-FITC antibodies or peroxidase-labeled NA/SA
reagents, respectively. In our study, we first evaluated the performance of the test using
MM3-biotin and NA-HRP reagents in order to modify our classic MM3-COPRO ELISA. How-
ever, as can be deduced from the results presented in Figs 2D and 3A, although the use of
NA-HRP to detect Fasciola L-cathepsins in fecal samples is highly specific and generates low
background levels, the ELISA detection ability was only slightly better than that obtained with
the current batch of HRP-labeled anti-mouse IgG polyclonal antibodies. Nevertheless, the per-
formance of the MM3-COPRO ELISA could be significantly improved by using biotinylated
MM3 and SA-PolyHRP as the amplification system. Regular NA-HRP and SA-HRP conjugates
are among the most frequently used immune detection molecules in ELISA for general applica-
tion. However, when detection of small amounts of analyte in samples is required, enhance-
ment systems that exploit the use of recognition molecules containing a large proportion of
enzymes may be required. Reagents based on this principle can be produced by the attachment
of the recognition molecules of interest and multiple enzyme molecules to a backbone of dex-
tran [34, 35] or by conjugation of polymeric HRP to multiple recognition molecules such as SA
[30].
Among the available enhancement systems, we decided to use SA-PolyHRP conjugates for
four main reasons: i) the coupling of biotin to mAbMM3 has previously been standardized
[10] and is already used in the commercial version of the kit (BIO K 201, BIO X Diagnostics);
ii) SA-PolyHRP is a versatile reagent available in different homopolymer lengths and from sev-
eral commercial sources; iii) it can directly substitute SA/NA-HRP in biotin-SA/NA based ELI-
SAs with minimal adjustments; and iv) although biotin is present in feces, as it is present in
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food and synthesized by intestinal flora [36], it does not interfere in our MM3-COPRO ELISA
because it is removed during subsequent washings before adding the SA-PolyHRP conjugate.
As noted in the previous section, the enhancement of MM3-COPRO ELISA values with
SA-PolyHRP enabled us to correctly classify all positive and negative samples, yielding an
excellent signal-to-noise ratio and a detection limit of 150 pg/mL; this low limit has not previ-
ously been achieved with methods of detecting Fasciola coproantigens. Moreover, considering
that the standard curve constructed for calibrating the assay uses the total protein content in
Fasciola ESAs and that L-cathepsins, although the most abundant [37], are not the only pro-
teins present, the true detection limit of the assay is expected to be even lower than 150 pg/mL.
ELISA methods that can detect very small amounts of Fasciola coproantigens are of great
interest, particularly given the high day-to-day variability in the antigen concentration in fecal
samples from large ruminants. In this sense, 2–6 fold variations in antigen concentration
throughout consecutive daily collections from cows infected with a medium to large number of
adult flukes in liver has already been reported [11]. Similarly, in the present study we observed
a high variability in coproantigen release in fecal samples collected weekly from cattle experi-
mentally infected with 25 and 50 metacercariae (Fig 7B). In addition, there were large differ-
ences (6–12 fold) in OD values of single samples obtained from cattle harboring only 1–10
flukes (Fig 4A). Considering fluke burdens, we also observed that OD differences were higher,
as expected, for fecal samples from cattle harboring a single adult fluke (OD range = 0.094–0.7;
model C) than for cattle parasitized with 6–10 flukes (OD range = 0.5–1.7; model C). This may
explain the absence of correlation between fluke burden and the OD values observed in the
present study (Fig 5D).
For animals with the lowest fluke burden (e.g. 1–4 parasites), we hypothesize that differ-
ences in the release of L-cathepsins in feces may be due to a different size/maturation status of
the flukes or due to the elapsed time between cyclic regurgitations. However, although the high
variability in antigen concentration in cows sampled daily/weekly was proposed to be related
either to biological effects of the parasite, the effects of developing pathology and immunity, or
changes in fecal consistency [11], such a high variation in cows with a high number of parasites
was never convincingly explained.
Unlike for the cattle samples, the results obtained with MM3-COPRO ELISA models B and
C testing sheep samples collected at 13 wpi showed similar high OD values independently of
fluke burden (2–28 flukes; Fig 4B). Fluctuations in antigen were less apparent in fecal samples
obtained weekly from sheep experimentally infected with 5 or 10 metacercariae (Fig 7A). This
can be explained by the fact that with the enhanced MM3-COPRO ELISA, the concentration
of antigen in feces is high enough to yield saturated OD values, even when variations in antigen
concentration occur. In agreement with this, in a study by Mezo et al. [9], coproantigen con-
centrations in experimentally infected lambs harboring 1–36 flukes were in all cases over 12
ng/mL, which would result in OD values higher than 1.0 with the enhanced MM3-COPRO
ELISA.
The observation that the OD values obtained with samples from animals with one or two
flukes may be higher than that of animals harboring, for example, 10 flukes (Fig 6), underlines
the importance of using highly sensitive ELISA methods as the proposed enhanced MM3-CO-
PRO ELISA. It could be argued that such sensitivity is not necessary, as it has been reported
that only animals harboring 10 or more flukes suffer significant hepatic damage [12]. However,
highly sensitive methods are required in at least three situations: i) poorly sensitive methods
cannot guarantee the detection of a positive animal by testing a single fecal sample due to the
high variability in L-cathepsins concentration in feces; ii) ultra-sensitive methods are particu-
larly useful for detecting the survival of flukes after anthelmintic treatment due to resistance,
which is of great interest to prevent spreading resistant strains; and iii) detection of animals
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with low fluke burdens may be of additional interest as it has been reported that Fasciola infec-
tions promote TH2 responses, which in turn may favor infections by certain pathogens and
even confound the diagnosis of diseases such as bovine tuberculosis, caused byMycobacterium
bovis [38]. Moreover, highly sensitive methods are essential for early diagnosis of human infec-
tions by F. hepatica or F. gigantica.
In addition to coproantigen determinations in fecal samples, the presence of fluke infections
within dairy herds can also be investigated by examining the presence of antibodies in serum
or in bulk tanks [6, 39]. However, for beef herds, composite fecal egg counts mixing feces from
up to 10 animals and further investigation of animals that contribute to the positive samples
are frequently used in sedimentation assays [40]. Pooled fecal samples have also been used with
the coproantigen ELISA in some studies [11, 13]. Although we cannot recommend a priori
analysis of coproantigen in composite fecal samples, as this practice can misdiagnose positive
animals particularly in days coincident with low coproantigen elimination, the improved sensi-
tivity of the enhanced MM3-COPRO reported in this study warrants further investigation of
this possibility.
Finally, as mAbMM3 also recognizes L-cathepsins from F. gigantica [41, 42] and the method
was already used for detection of F. gigantica coproantigens in feces of sheep experimentally
infected with this species [43], it is expected that the ELISA modifications proposed here are also
applicable in regions where only F. gigantica or both species are present. However, as the consis-
tency and alimentation of animals may differ from one region to another, and the polyclonal
antibodies used to capture antigens in the MM3-COPRO ELISA were produced using ESAs from
F. hepatica, adaptation of cut-off values and/or substitution of the polyclonal antibodies by others
obtained by immunizing rabbits with ESAs from F. giganticamay be necessary.
In summary, the MM3-COPRO ELISA is improved by incorporating the SA-PolyHRP as a
detection system, thus yielding a robust method that can detect very low levels of antigen in
feces from animals infected with Fasciola hepatica and that enables detection of infection in
cattle parasitized with a single fluke. Moreover, this method was able to correctly classify posi-
tive animals throughout the patent period considered in experimental infections. This may
solve sensitivity-related problems caused by the broad daily antigen oscillations observed in
large ruminants. As the classic MM3-COPRO ELISA has already been tested with human fecal
samples [10, 29] the proposed modification is also expected to be useful for improving the
early diagnosis of human infections by Fasciola species after adjusting the cut-off value. Prelim-
inary studies being carried out in our laboratory with fecal human samples seem to confirm
this expectation.
Limitations
The limitations of the study lay in the small sample size, which was conditioned by the avail-
ability of eligible samples and the complexity of performing multiple simultaneous test com-
parisons. Nevertheless, we estimate that the number of samples used was adequate to draw
robust conclusions about the better performance of the MM3-COPRO test using the SA-Po-
lyHRP conjugate with respect to the other secondary reagents evaluated, which was the main
purpose of this study. This does not preclude that future studies conducted with a large number
of samples from areas of different disease prevalence, feeding and farming conditions are
required to obtain definitive conclusions about the performance of the proposed methodology.
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